Award
Delivery Order #SPE2DR26FCPJ8
Delivery Order for Brimonidine Eye Drops under Pharmaceutical Supply Contract
Buyer
Defense Logistics Agency
Award Amount
$34.50
Ceiling
$34.50
Awarded
February 11, 2026
Period of Performance
Feb 11, 2026 – Feb 12, 2026
Identifier
SPE2DR26FCPJ8
NAICS
424210
This award represents a delivery order contract issued to DMS Pharmaceutical Group Inc., a company specializing in pharmaceutical supply and healthcare products. The order procures Brimonidine 0.2% eye drops in 10ml bottles, aimed at supporting ophthalmic treatments within federal health programs. As a delivery order under an existing indefinite delivery vehicle (IDV) pharmaceutical contract, it ensures timely provision of essential medications. This multi-year IDV contract with DMS Pharmaceutical Group Inc. provides a strategic supply framework critical for maintaining the availability of vital pharmaceuticals to the public sector. The contract's scope includes the precise delivery of specified pharmaceutical products, adhering to quality standards. This delivery order was awarded competitively within the established vehicle, underscoring procurement efficiency. The performance period for this order is short-term, spanning two days in early 2026, reflecting the immediate need for these medical supplies. The contract contributes significantly to federal healthcare initiatives by guaranteeing the availability of key eye-care medication.
Description
4570886839!BRIMONIDINE 0.2% EYE DROP 10ML